KA87.2
category
Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugation
Definition
A paediatric condition characterised by persistently increased level of bilirubin above 85 umol/l (5 mg/dL) manifesting as yellowing of the eyes, skin, and other tissues of a newborn due to any chemical substance that prevents or decreases the production of breast milk by the mother.
Also indexed as
Neonatal hyperbilirubinaemia due to breast milk inhibitor of bilirubin conjugationbreast milk inhibitor jaundicebreast-feeding inhibitors causing neonatal jaundicebreast-milk jaundicefetal jaundice, due to or associated with breast milk inhibitorsjaundice due to delayed conjugation from causes such as breast milk inhibitorsneonatal jaundice due to delayed conjugation from breast milk inhibitorsprolonged neonatal unconjugated hyperbilirubinaemia
Nearby in Neonatal hyperbilirubinaemia
KA87.0Neonatal hyperbilirubinaemia due to swallowed maternal bloodKA87.1Neonatal hyperbilirubinaemia due to enzymatic defect in bilirubin degradationKA87.3Neonatal hyperbilirubinaemia due to total parenteral nutritionKA87.4Neonatal hyperbilirubinaemia due to drugs or toxins transmitted from motherKA87.5Neonatal hyperbilirubinaemia due to drugs or toxins given to newbornKA87.6Neonatal hyperbilirubinaemia from other or unspecified hepatocellular damage4B4YOther specified diseases of the immune system4B4ZDiseases of the immune system, unspecified